{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:10:39Z","timestamp":1779189039982,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cytarabine (CYT) is a cornerstone in the treatment of acute myeloid leukemia (AML) and is often co-administered with granisetron (GRS) to manage chemotherapy-induced nausea and vomiting (CINV). A precise and sensitive thin-layer chromatographic (TLC) method was developed and validated for the simultaneous determination of CYT and GRS in spiked human plasma samples. Chromatographic separation was achieved by using a developing system consisting of ethyl acetate, ethanol, and ammonia (3:6.8:0.2, by volume), and detection was performed at 240\u00a0nm. The method exhibited linearity over the concentration ranges of 0.5\u20133.0\u00a0\u00b5g\/band for the pure samples and 0.5\u20133.3\u00a0\u00b5g\/band in spiked plasma for the analytes. The proposed method was validated in accordance with the guidelines of the U.S. Food and Drug Administration (FDA). Its environmental sustainability was evaluated using the Modified Green Analytical Procedure Index, Analytical Greenness Calculator, and Multicolor Assessment Index, demonstrating strong performance with minor areas for improvement. Notably, this study presents the first green TLC method for the simultaneous determination of CYT and GRS in spiked human plasma, offering a valuable tool for therapeutic drug monitoring during chemotherapy.<\/jats:p>","DOI":"10.1186\/s13065-026-01821-1","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T02:43:51Z","timestamp":1779158631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Green TLC-densitometric method for determination\u00a0of cytarabine and granisetron in spiked human plasma: optimization and whiteness assessment"],"prefix":"10.1186","volume":"20","author":[{"given":"Salwa I.","family":"Tohamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eglal A.","family":"Abdelaleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel","family":"Lashien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud M.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nessreen S.","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"7","key":"1821_CR1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1182\/blood-2017-04-777722","volume":"130","author":"KN Magina","year":"2017","unstructured":"Magina KN, Pregartner G, Zebisch A, W\u00f6lfler A, Neumeister P, Greinix HT, et al. Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis. Blood. 2017;130(7):946\u20138. https:\/\/doi.org\/10.1182\/blood-2017-04-777722.","journal-title":"Blood"},{"issue":"1","key":"1821_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2165\/00003495-198300251-00008","volume":"25","author":"J Laszlo","year":"1983","unstructured":"Laszlo J. Antiemetics and cancer chemotherapy. Drugs. 1983;25(1):74\u201389.","journal-title":"Drugs"},{"issue":"4","key":"1821_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s005200050078","volume":"5","author":"D Osoba","year":"1997","unstructured":"Osoba D, Zee B, Warr D, Latreille J, Kaizer L, Pater J. Effect of postchemotherapy nausea and vomiting on health-related quality of life. Support Care Cancer. 1997;5(4):307\u201313. https:\/\/doi.org\/10.1007\/s005200050078.","journal-title":"Support Care Cancer"},{"issue":"10","key":"1821_CR4","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0959-8049(97)00160-3","volume":"33","author":"V Kirchner","year":"1997","unstructured":"Kirchner V, Aapro M, Terrey JP, Alberto P. A double-blind crossover study comparing prophylactic intravenous granisetron alone or in combination with dexamethasone as antiemetic treatment. Eur J Cancer. 1997;33(10):1605\u201310. https:\/\/doi.org\/10.1016\/S0959-8049(97)00160-3.","journal-title":"Eur J Cancer"},{"issue":"4","key":"1821_CR5","first-page":"51","volume":"5","author":"V Murthy","year":"2013","unstructured":"Murthy V, Rohini A, Pravallika K, Rani AP, Rahaman S. Development and validation of a novel UV-visible spectrophotometric method for cytarabine in bulk and pharmaceutical dosage forms. Der Pharm Lett. 2013;5(4):51\u20135.","journal-title":"Der Pharm Lett"},{"issue":"4","key":"1821_CR6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/dta.297","volume":"5","author":"II Hewala","year":"2013","unstructured":"Hewala II, Bedair MM, Shousha SM. First derivative spectrophotometric determination of granisetron hydrochloride in the presence of its hydrolytic products and preservative. Drug Test Anal. 2013;5(4):234\u201341. https:\/\/doi.org\/10.1002\/dta.297.","journal-title":"Drug Test Anal"},{"issue":"4","key":"1821_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jccs.201190004","volume":"58","author":"E Souri","year":"2011","unstructured":"Souri E, Kargar Z, Saremi S, Ravari NS, Alvandifard F, Amanlou M. Development and validation of a stability-indicating HPLC method for determination of granisetron. J Chin Chem Soc. 2011;58(4):443\u20139. https:\/\/doi.org\/10.1002\/jccs.201190004.","journal-title":"J Chin Chem Soc"},{"issue":"8","key":"1821_CR8","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1080\/00032719208017131","volume":"25","author":"M Mahrous","year":"1992","unstructured":"Mahrous M, Abdel-Khalek M, Daabees H, Beltagy Y. Use of differential spectrophotometry for determination of cytarabine and acyclovir in their dosage forms. Anal Lett. 1992;25(8):1491\u2013501. https:\/\/doi.org\/10.1080\/00032719208017131.","journal-title":"Anal Lett"},{"issue":"1","key":"1821_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s10812-019-00904-3","volume":"86","author":"V Montazeralmahdi","year":"2019","unstructured":"Montazeralmahdi V, Sheibani A, Shishehbore MR. First and third derivative spectrophotometry for simultaneous determination of dexamethasone and cytarabine in pharmaceutical formulations and biological fluids. J Appl Spectrosc. 2019;86(1):843\u20137. https:\/\/doi.org\/10.1007\/s10812-019-00904-3.","journal-title":"J Appl Spectrosc"},{"issue":"14","key":"1821_CR10","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.4155\/bio.11.140","volume":"3","author":"MJ Hilhorst","year":"2011","unstructured":"Hilhorst MJ, Hendriks G, van Hout MW, Sill\u00e9n H, van de Merbel NC. HPLC\u2013MS\/MS method for the determination of cytarabine in human plasma. Bioanalysis. 2011;3(14):1603\u201311. https:\/\/doi.org\/10.4155\/bio.11.140.","journal-title":"Bioanalysis"},{"issue":"3","key":"1821_CR11","first-page":"160","volume":"7","author":"A Bhatnagar","year":"2012","unstructured":"Bhatnagar A, Loura S, Chaudhary M. A stability-indicating RP-HPLC method for determination of the anticancer agent cytarabine in lyophilized dosage form. Eurasian J Anal Chem. 2012;7(3):160\u20137.","journal-title":"Eurasian J Anal Chem"},{"issue":"1\u20132","key":"1821_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jchromb.2007.03.034","volume":"854","author":"Y Hsieh","year":"2007","unstructured":"Hsieh Y, Duncan CJ, Liu M. A mixed-mode liquid chromatography-tandem mass spectrometric method for the determination of cytarabine in mouse plasma. J Chromatogr B Anal Technol Biomed Life Sci. 2007;854(1\u20132):8\u201312. https:\/\/doi.org\/10.1016\/j.jchromb.2007.03.034.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"12","key":"1821_CR13","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.13040\/IJPSR.0975-8232.4(12).4573-76","volume":"4","author":"VS Murthy","year":"2013","unstructured":"Murthy VS, Rohini A, Pravallika K, Rani AP, Rahaman S. Development and validation of RP-HPLC method for estimation of cytarabine in bulk and pharmaceutical dosage forms. Int J Pharm Sci Res. 2013;4(12):4573\u20137. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.4(12).4573-76.","journal-title":"Int J Pharm Sci Res"},{"issue":"9","key":"1821_CR14","first-page":"1411","volume":"27","author":"Q Liu","year":"2007","unstructured":"Liu Q, Pan WF, Wu Y, Wu XH, Chen GL. HPLC determination of cytarabine hydrochloride for injection and its related substances. Chin J Pharm Anal. 2007;27(9):1411\u20135.","journal-title":"Chin J Pharm Anal"},{"issue":"1","key":"1821_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jpba.2022.114582","volume":"21","author":"S Huang","year":"2022","unstructured":"Huang S, Liu L, Liu X, Song L, Huang C, Miao L. Development and application of a rapid and sensitive liquid chromatography-mass spectrometry method for simultaneous analysis of cytarabine and its metabolites. J Pharm Biomed Anal. 2022;21(1):114\u201352. https:\/\/doi.org\/10.1016\/j.jpba.2022.114582.","journal-title":"J Pharm Biomed Anal"},{"issue":"10","key":"1821_CR16","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1021\/ac062441s","volume":"79","author":"Y Hsieh","year":"2007","unstructured":"Hsieh Y, Li F, Duncan CJ. Supercritical fluid chromatography and high-performance liquid chromatography\/tandem mass spectrometric methods for the determination of cytarabine in mouse plasma. Anal Chem. 2007;79(10):3856\u201361. https:\/\/doi.org\/10.1021\/ac062441s.","journal-title":"Anal Chem"},{"issue":"1","key":"1821_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jchromb.2008.05.033","volume":"870","author":"Y Sun","year":"2008","unstructured":"Sun Y, Sun J, Wen B, Shi S, Xu Y, Chen Y, et al. High-performance liquid chromatography\/tandem mass spectrometry method for the simultaneous determination of cytarabine and valcytarabine in rat plasma. J Chromatogr B. 2008;870(1):121\u20135. https:\/\/doi.org\/10.1016\/j.jchromb.2008.05.033.","journal-title":"J Chromatogr B"},{"issue":"1","key":"1821_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.54037\/WJPS.2022.100104","volume":"10","author":"UM Katari","year":"2022","unstructured":"Katari UM, Ajitha M. Stability indicating method development and validation for determination of daunorubicin and cytarabine in bulk and pharmaceutical dosage form by RP-HPLC. World J Pharm Sci. 2022;10(1):41\u201351. https:\/\/doi.org\/10.54037\/WJPS.2022.100104.","journal-title":"World J Pharm Sci"},{"issue":"1","key":"1821_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13065-024-01184-5","volume":"18","author":"MA Magdy","year":"2024","unstructured":"Magdy MA, Elgebaly AM, Taha AA, Ali NW, Farid NF. Two chromatographic methods for determination of cytarabine and dexamethasone, two co-administered drugs for the treatment of leukemia: a green analytical perspective. BMC Chem. 2024;18(1):88\u201392. https:\/\/doi.org\/10.1186\/s13065-024-01184-5.","journal-title":"BMC Chem"},{"issue":"4","key":"1821_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.22270\/jddt.v9i4.3061","volume":"9","author":"A Agrawal","year":"2019","unstructured":"Agrawal A, Sharma M. Bioanalytical method development and validation for estimation of daunorubicin and cytarabine in blood plasma by using RP-HPLC. J Drug Deliv Ther. 2019;9(4):366\u201373. https:\/\/doi.org\/10.22270\/jddt.v9i4.3061.","journal-title":"J Drug Deliv Ther"},{"issue":"6","key":"1821_CR21","first-page":"14","volume":"5","author":"B Sinduja","year":"2022","unstructured":"Sinduja B, Saibaba SV, Badri B, Aparna B, Navya P, et al. Validated reverse phase stability-indicating HPLC method for estimating anticancer drugs cytarabine and clofarabine. J Innov Dev Pharm Tech Sci. 2022;5(6):14\u20139.","journal-title":"J Innov Dev Pharm Tech Sci"},{"issue":"1","key":"1821_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0378-4347(00)80248-0","volume":"225","author":"H Breithaupt","year":"1981","unstructured":"Breithaupt H, Schick J. Determination of cytarabine and uracil arabinoside in human plasma and cerebrospinal fluid by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1981;225(1):99\u2013106. https:\/\/doi.org\/10.1016\/S0378-4347(00)80248-0.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"2","key":"1821_CR23","first-page":"252","volume":"4","author":"SA Kanchana","year":"2011","unstructured":"Kanchana SA, Aruna A, Niraimathi V, Suresh AJ. Spectrophotometric estimation of granisetron in bulk and tablet formulation. Res J Pharm Technol. 2011;4(2):252\u20133.","journal-title":"Res J Pharm Technol"},{"issue":"3","key":"1821_CR24","first-page":"634","volume":"3","author":"P Panzade","year":"2010","unstructured":"Panzade P, Puranik P, Mogal V, Patni M. Development and validation of UV spectrophotometric method of granisetron hydrochloride in bulk and pharmaceutical formulation. Asian J Res Chem. 2010;3(3):634\u20136.","journal-title":"Asian J Res Chem"},{"issue":"4","key":"1821_CR25","first-page":"928","volume":"3","author":"RA Balap","year":"2010","unstructured":"Balap RA, Prasad VD, Khidse SA, Shailaja BJ, Joshi S, Chaudhari PD. Development and validation of spectrophotometric methods for estimation of granisetron hydrochloride in pure and pharmaceutical dosage forms. Asian J Res Chem. 2010;3(4):928\u201331.","journal-title":"Asian J Res Chem"},{"issue":"2","key":"1821_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.56808\/3027-7922.2437","volume":"44","author":"AM Hamed Bellah","year":"2020","unstructured":"Hamed Bellah AM, Mohamed AMI, Mohamed NAL. Development and validation of RP-HPLC method for simultaneous determination of ondansetron hydrochloride and granisetron hydrochloride. Thai J Pharm Sci. 2020;44(2):82\u201390. https:\/\/doi.org\/10.56808\/3027-7922.2437.","journal-title":"Thai J Pharm Sci"},{"issue":"6","key":"1821_CR27","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4103\/0250-474X.100255","volume":"73","author":"A Heda","year":"2011","unstructured":"Heda A, Kathiriya J, Gadade D, Puranik P. Development and validation of RP-HPLC method for simultaneous determination of granisetron and dexamethasone. Indian J Pharm Sci. 2011;73(6):696\u20139.","journal-title":"Indian J Pharm Sci"},{"issue":"1","key":"1821_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.talanta.2010.04.017","volume":"82","author":"I Hewala","year":"2010","unstructured":"Hewala I, El-Fatatry H, Emam E, Mubrouk M. Development and application of a validated stability-indicating HPLC method for simultaneous determination of granisetron hydrochloride and benzyl alcohol. Talanta. 2010;82(1):184\u201395. https:\/\/doi.org\/10.1016\/j.talanta.2010.04.017.","journal-title":"Talanta"},{"issue":"4","key":"1821_CR29","first-page":"257","volume":"20","author":"B Xia","year":"2000","unstructured":"Xia B, Wu Q, He G. Determination of granisetron hydrochloride tablets by HPLC. Chin J Pharm Anal. 2000;20(4):257\u20138.","journal-title":"Chin J Pharm Anal"},{"issue":"6","key":"1821_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7324\/JAPS.2013.3633","volume":"3","author":"M Mabrouk","year":"2013","unstructured":"Mabrouk M, El-Fatatry H, Hewala I, Emam E. Stability-indicating HPLC-DAD method for the determination of granisetron hydrochloride in its pharmaceutical preparations. J Appl Pharm Sci. 2013;3(6):189\u2013202. https:\/\/doi.org\/10.7324\/JAPS.2013.3633.","journal-title":"J Appl Pharm Sci"},{"key":"1821_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6749087","volume":"2017","author":"FC Chen","year":"2017","unstructured":"Chen FC, Wang LH, Guo J, Shi XY, Fang BX. Simultaneous determination of dexamethasone, ondansetron, granisetron, tropisetron, and azasetron in infusion samples by HPLC with DAD detection. J Anal Methods Chem. 2017;2017:6749087. https:\/\/doi.org\/10.1155\/2017\/6749087.","journal-title":"J Anal Methods Chem"},{"issue":"1","key":"1821_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0378-4347(95)00335-5","volume":"675","author":"F Pinguet","year":"1996","unstructured":"Pinguet F, Bressolle F, Martel P, Salabert D, Astre C. High-performance liquid chromatographic determination of granisetron in human plasma. J Chromatogr B Anal Technol Biomed Life Sci. 1996;675(1):99\u2013105. https:\/\/doi.org\/10.1016\/0378-4347(95)00335-5.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"9","key":"1821_CR33","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/chromsci\/bmz062","volume":"57","author":"MA Tantawy","year":"2019","unstructured":"Tantawy MA, Alweshahy S, Elshabasy DA, Youssef NF. Simultaneous determination of co-administered deflazacort, aprepitant, and granisetron in dosage forms and spiked human plasma by RP-HPLC\/PAD. J Chromatogr Sci. 2019;57(9):790\u20138. https:\/\/doi.org\/10.1093\/chromsci\/bmz062.","journal-title":"J Chromatogr Sci"},{"issue":"4","key":"1821_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jpba.2006.05.001","volume":"42","author":"Y Jiang","year":"2006","unstructured":"Jiang Y, Lin M, Fan G, Chen Y, Li Z, Zhao W, et al. Rapid determination of granisetron in human plasma by liquid chromatography coupled to tandem mass spectrometry. J Pharm Biomed Anal. 2006;42(4):464\u201373.","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"1821_CR35","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/jaoac\/94.5.1447","volume":"94","author":"I Hewala","year":"2011","unstructured":"Hewala I, El-Fatatry H, Emam E, Mabrouk M. Development and application of a validated stability-indicating HPLC method for simultaneous determination of granisetron and preservatives. J AOAC Int. 2011;94(5):1447\u201360. https:\/\/doi.org\/10.1093\/jaoac\/94.5.1447.","journal-title":"J AOAC Int"},{"issue":"4","key":"1821_CR36","first-page":"594","volume":"4","author":"SV Rao","year":"2012","unstructured":"Rao SV, Ramu G, Rambabu DRKC. A new isocratic RP-HPLC method development for the assay of granisetron HCl in API and dosage forms. Int J Pharm Pharm Sci. 2012;4(4):594\u20138.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"2","key":"1821_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/14740338.2019.1568988","volume":"18","author":"P Patel","year":"2019","unstructured":"Patel P, Paw Cho E, Dupuis LL. Safety of clinical practice guideline-recommended antiemetic agents for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric patients. Expert Opin Drug Saf. 2019;18(2):97\u2013110. https:\/\/doi.org\/10.1080\/14740338.2019.1568988.","journal-title":"Expert Opin Drug Saf"},{"key":"1821_CR38","volume-title":"Bioanalytical Method Validation Guidance for Industry","author":"U.S. Food and Drug Administration","year":"2018","unstructured":"U.S. Food and Drug Administration. Bioanalytical Method Validation Guidance for Industry. Silver Spring, MD: FDA; 2018."},{"key":"1821_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2024.100126","volume":"10","author":"FR Mansour","year":"2024","unstructured":"Mansour FR, Omer KM, P\u0142otka-Wasylka J. A total scoring system and software for complex modified GAPI (ComplexMoGAPI) application in the assessment of method greenness. Green Anal Chem. 2024;10:100126.","journal-title":"Green Anal Chem"},{"key":"1821_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116223","volume":"138","author":"PM Nowak","year":"2021","unstructured":"Nowak PM, Wietecha-Rianuszka R, Pawliszyn J, Ko\u015bcielniak P. White analytical chemistry: an approach to a comprehensive evaluation of analytical methods. TrAC Trends Anal Chem. 2021;138:116230.","journal-title":"TrAC Trends Anal Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-026-01821-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01821-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01821-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:54:15Z","timestamp":1779188055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13065-026-01821-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1821"],"URL":"https:\/\/doi.org\/10.1186\/s13065-026-01821-1","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}